Free Trial

Nutex Health (NASDAQ:NUTX) Given "Hold (C-)" Rating at Weiss Ratings

Nutex Health logo with Medical background

Key Points

  • Nutex Health's stock has been given a "hold (C-)" rating by Weiss Ratings and has seen a recent price target set at $205.00 from Maxim Group.
  • The stock has experienced a 7.1% increase recently, with current trading at around $125.57 and the average price target set at $252.50.
  • Institutional investors have made significant moves, with investments from groups like Bank of America Corp DE increasing their holdings by over 6,590% in the fourth quarter.
  • Five stocks to consider instead of Nutex Health.

Nutex Health (NASDAQ:NUTX - Get Free Report)'s stock had its "hold (c-)" rating restated by analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

NUTX has been the subject of a number of other reports. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, October 18th. Maxim Group set a $205.00 target price on Nutex Health and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $252.50.

Check Out Our Latest Report on Nutex Health

Nutex Health Stock Up 7.1%

NUTX stock opened at $125.57 on Friday. The stock has a market cap of $698.17 million, a PE ratio of 10.56 and a beta of -0.20. The firm's 50-day simple moving average is $97.19 and its 200 day simple moving average is $114.48. Nutex Health has a fifty-two week low of $21.55 and a fifty-two week high of $184.27. The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue acquired a new position in Nutex Health in the 3rd quarter worth about $30,000. BNP Paribas Financial Markets increased its holdings in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock worth $40,000 after buying an additional 290 shares during the last quarter. Ameritas Investment Partners Inc. bought a new position in Nutex Health during the second quarter valued at approximately $44,000. Bank of America Corp DE lifted its stake in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after acquiring an additional 2,043 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in Nutex Health in the second quarter worth approximately $97,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.